All 1 Debates between Dave Doogan and Alex Cunningham

UK Chemical Industry: Regulatory Divergence

Debate between Dave Doogan and Alex Cunningham
Wednesday 26th February 2020

(4 years, 9 months ago)

Westminster Hall
Read Full debate Read Hansard Text Read Debate Ministerial Extracts

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Dave Doogan Portrait Dave Doogan (Angus) (SNP)
- Hansard - -

I am very happy to sum up for the Scottish National party in this important debate, whose importance belies its attendance. In the first instance, I echo the sentiments of the hon. Member for Sefton Central (Bill Esterson), who secured the debate, by pointing out that little or no manufacturing takes place without almost total dependence on the chemical manufacturing sector and the regulation that underpins that—both domestically in the United Kingdom and, just as importantly, around the world.

Across all manufacturing sectors, we see the clearest indications from stakeholders, whether commercial, trade union or in processing, that we live in a world of very integrated international supply chains, and we have done for some time. They are dependent on regulatory alignment. It is also worth pointing out the amount of research and development money that goes into the chemical industry, much of it private—how that interacts with our higher education sector, the role the United Kingdom plays in that and how we discharge that role with our international partners, many of whom are in the European Union.

Alex Cunningham Portrait Alex Cunningham
- Hansard - - - Excerpts

The hon. Member mentions research and development, and we are of course dealing with multinational companies with plants all over the world. If they are going to do research and development, surely they will do that in areas where they have common regulations such as REACH, rather than in a future British chemical industry, which could be a backwater.

Dave Doogan Portrait Dave Doogan
- Hansard - -

The hon. Member is right, and the risk that the United Kingdom runs in seeking to pursue some alternate regulatory framework is exactly as he sets out: industry will produce its products to be compliant with the regulation consistent with the size of the market opportunity—it is not a blanket approach. If a market is subject to a particular regulatory framework, but that market is not big enough for the industry to comply with the framework, they simply will not comply and those products will not be available in a post-Brexit, post-REACH-regulation United Kingdom.

As we roll the dice on this issue, it is important to understand the slightly rarefied position occupied by the chemical industry in the United Kingdom. It has a turnover of £56.6 billion, but a very enviable gross value added of £19.2 billion. The Government must tread carefully and pay close attention to the members within trade organisations, such as the Chemical Industries Association and others, who are very clear with their call for regulatory alignment.

We have heard an awful lot about the cost of the re-creation of some successor to EU REACH, which is as yet unspecified, but I genuinely, thoroughly believe that the point is moot. As Members have said, the industry will offshore the UK manufacturing of chemicals. Other industries within the UK that rely on the products of the chemical industry will be subject to buying from another market. That will in all likelihood be the European Union, so we will then face the farcical situation of having dispensed with REACH regulations here—which will have cost us our industry, or a large part of it—and of then being in possession of the very same standard of product purchased from the EU, just without the £56.6 billion of turnover, or a large part thereof, and the jobs that went with it. The stakes are no lower than that! Having said that, were the UK to press ahead with some parallel regulatory framework for chemicals, the resultant animal testing, as others have mentioned, would be held in contempt by society, and rightly so. It is important to bear that in mind.

The regulation and supply of chemicals is yet another area of huge complexity in that Brexit ambition. Brexit will have an impact on the chemical industry driven by changing regulatory requirements, as others have mentioned, and by other trade barriers, potentially including tariffs and quotas. The REACH chemicals regulations are but one example of directly applicable EU legislation that is not straightforward to copy across into UK law. The principal objective remains, however, to ensure that those regulations still have priority in a post-Brexit United Kingdom dynamic. That is because the regulations rely on the European Chemicals Agency and are closely tied to the needs of the single market. The UK and EU chemical industries both want trade deals to ensure frictionless trade and regulatory consistency between the UK and the EU. That points to the complex supply chains that exist for the manufacturing sector.

I am very glad that the hon. Member for Sefton Central, who secured the debate, mentioned potassium chromate. As a former aircraft engineer, I still remember keenly the sweet smell of that sticky green substance which was difficult to get out from under the fingernails. Its role in preventing dissimilar metal corrosion in aircraft is well known and vital. That had the effect of taking me slightly down memory lane.

In conclusion, as a Scottish and a Scottish National party MP, I have no hesitation in supporting the ambitions of the hon. Member. The UK is a key global player in the chemical industries just now. As far as I can tell, the only chemical company in the UK in the top five chemical companies in the world is INEOS, which has a major presence in Grangemouth in Scotland. The Chemical Industries Association also covers the pharmaceutical industry, and I am very privileged to have in my constituency of Angus an extraordinarily large and important GlaxoSmithKline plant. Nowhere does interdependence and mutual reliance on common regulation apply more than in that plant.

Alex Cunningham Portrait Alex Cunningham
- Hansard - - - Excerpts

INEOS has been in my constituency as well, but it is actually closing down a plant there; the plant has finished because it is past its use-by date. INEOS can invest billions of pounds in the middle east, but nothing in Britain at this time. For me, the main issue is what the hon. Gentleman has talked about: the integrated nature of the chemical industry. The industry is losing a key component; if there are changes in regulations over time, more and more of those parts will disappear. We will therefore be reliant on the imports that the hon. Gentleman mentioned.

Dave Doogan Portrait Dave Doogan
- Hansard - -

Indeed. I am not here to defend or uphold the commercial decisions of INEOS, but what the industry more generally needs at this minute is clarity and certainty from Government, as far as that is possible. I look forward to the Minister explaining how the Government will give the industry the confidence and certainty that will enable them to invest in plants in Scotland and the rest of the UK. Those plants’ return on investment may take decades, and it is extremely important that we give them every opportunity to invest in infrastructure and jobs, with the attendant benefits that those bring to our communities.

Over and above the material contemporary considerations of the chemical industry, this issue is important for the livelihoods of many people in Scotland and in my constituency of Angus. Of course, industrial production of chemicals first began in Scotland, with the industrial production of bleach just north of Glasgow. We have moved a long way in the intervening 150 years, and I would hate for us to start moving back as a consequence of Brexit.